Both semaglutide and tirzepatide for type 2 diabetes and weight loss are GLP-1 agonists, meaning they mimic the hormone.

This change is happening because there’s another covered medication that’s safe and effective for your condition and may cost ...

Three people share the hoops they've jumped through, financial strain they've endured and risks they've taken on in order to ...

Top executives ignored warnings that the company was not sufficiently prepared for the launch of its weight-loss drug Wegovy, leaving the drugmaker in a more vulnerable position when rival Eli Lilly ...

Novo Nordisk executives overlooked warnings ahead of Wegovy's launch, leading to supply issues, high costs, and challenges competing with Eli Lilly's Zepbound.

Tara Eacobacci had an appointment with her doctor that was devoted exclusively to the topic of health insurance. A major ...

In the same way weight varies from person to person, so do the best weight loss strategies. While some people succeed with ...

Joe Gebbia, a confidant of the technology billionaire and a Tesla director, is also a leader of the federal cost-cutting team ...

"Employers have absorbed the majority of cost increases over the past four years, and they likely cannot continue to do so," ...

Innovation in obesity treatments, Alzheimer's detection and medical-device applications is setting the stage for a number of ...